Thomas W. Beetham

General Counsel, Kiniksa Pharmaceuticals International, plc.

Companies

Viridian Therapeutics, Inc.\DEChief operating officer Nov 1, 2023 to now¹
Magenta TherapeuticsOfficer Jun 15, 2021 to Dec 2, 2022²
Kiniksa Pharmaceuticals International, plcGeneral counsel May 23, 2018 to Mar 23, 2021³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARViridian Therapeutics, Inc.\DE, Chief operating officer
2
SEC EDGARMagenta Therapeutics, Officer
3
SEC EDGARKiniksa Pharmaceuticals International, plc, General counsel